Expression of CD21 on Labeled PBLs and Labeled TDLs Recovered From Blood and Lymph 3 to 18 Days After Labeling and Intravenous Reinjection (n = 5)
| Antibody . | Labeled TDLs . | Labeled PBLs . | ||
|---|---|---|---|---|
| . | Lymph . | Blood . | Lymph . | Blood . |
| B cells | 26.8 ± 6.7 | 24.6 ± 4.4 | 21.6 ± 5.4 | 63.2 ± 13.8 |
| CD21 | 26.8 ± 8.4 | 23.5 ± 3.4 | 22.3 ± 5.8 | 26.1 ± 6.5 |
| Antibody . | Labeled TDLs . | Labeled PBLs . | ||
|---|---|---|---|---|
| . | Lymph . | Blood . | Lymph . | Blood . |
| B cells | 26.8 ± 6.7 | 24.6 ± 4.4 | 21.6 ± 5.4 | 63.2 ± 13.8 |
| CD21 | 26.8 ± 8.4 | 23.5 ± 3.4 | 22.3 ± 5.8 | 26.1 ± 6.5 |
Antibody 2-8 was used to identify all B cells, and antibody 2-128 identified CD21+ lymphocytes. Data are presented as the mean percentage of labeled cells ± SE.